verified SJR 0,572 · Q3 • database Scopus / SJR & Web of Science & DOAJ indexed

United States · John Wiley and Sons Ltd

workspace_premium Q3 — Immunology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

International Journal of Rheumatology

International Journal of Rheumatology is a journal indexed in SJR in Immunology and Rheumatology with an H index of 43. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 922,5 €. The scope of the journal is focused on rheumatology, arthritis. It has an SJR impact factor of 0,572 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,572.

ISSN: 1687-9260

Publisher: John Wiley and Sons Ltd

Category: Immunology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,572 Q3

H-index 43

Acceptance rate pie_chart

33%

Source Acceptance_Rate

Time to publication hourglass_top

24 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

923 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,572

H-index

Docs (year)

Docs 3y

Total refs

352

Cites 3y

Citable 3y

Cites/Doc 2y

1.69

Ref/Doc

44.0

Immediate OA

922,5 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biological Therapy in Systemic Lupus Erythematosus

Wrist Arthrodesis in Rheumatoid Arthritis Using an LCP Metaphyseal Locking Plate versus an AO Wrist Fusion Plate

Contact Frequency, Travel Time, and Travel Costs for Patients with Rheumatoid Arthritis

Comparison of the Systemic Lupus Erythematosus Activity Questionnaire and the Systemic Lupus Erythematosus Disease Activity Index in a Black Barbadian Population

Comment on "The Role of Citrullinated Protein Antibodies in Predicting Erosive Disease in Rheumatoid Arthritis: A Systematic Literature Review and Meta-Analysis"

Clinically Apparent Arterial Thrombosis in Persons with Systemic Vasculitis

Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation

Clinical and Autoimmune Profile of Scleroderma Patients from Western India

Carotid Intima Media Thickness as a Marker of Atherosclerosis in Ankylosing Spondylitis

Cardiopulmonary Manifestations of Ankylosing Spondylitis

Capability and Limitations of Recent Diagnostic Criteria for Autoimmune Pancreatitis

Bone Mineral Density in Cystic Fibrosis Patients with the CFTR I1234V Mutation in a Large Kindred Family Is Associated with Pancreatic Sufficiency

SHOW MORE ARTICLES

Biologicals

A Child with X-Linked Agammaglobulinemia and Enthesitis-Related Arthritis

Biologic Agents - A Panacea for Inflammatory Arthritis or Not?

Behcet's Disease: Is There Geographical Variation? A Review Far from the Silk Road

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

Asymptomatic Atherosclerosis in Egyptian Rheumatoid Arthritis Patients and Its Relation to Disease Activity

Are There Clinical Differences in Limited Systemic Sclerosis according to Extension of Skin Involvement?

Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac

Apoptosis Modulation as a Promising Target for Treatment of Systemic Sclerosis

Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood

Anti-a-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights

Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review

FAQs

International Journal of Rheumatology has an SJR of 0,572 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 922,5 EUR.

The acceptance rate recorded for International Journal of Rheumatology is 33%.

International Journal of Rheumatology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of International Journal of Rheumatology?

What is the APC / publication cost?

What is the acceptance rate?